Inhibitors of apoptosis proteins in human cervical cancer
2006

Inhibitors of apoptosis proteins in human cervical cancer

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Espinosa Magali, CantĂș David, Herrera Norma, Lopez Carlos M, De la Garza Jaime G, Maldonado Vilma, Melendez-Zajgla Jorge

Primary Institution: Instituto Nacional de CancerologĂ­a, Mexico City, Mexico

Hypothesis

The study investigates the expression of c-IAP1, c-IAP2, XIAP, and survivin in cervical cancer.

Conclusion

The study found that XIAP expression correlates with disease relapse in cervical cancer patients, while survivin was upregulated in cancer samples.

Supporting Evidence

  • Cervical tumors had lower c-IAP1 mRNA levels compared to normal tissues.
  • A significant inverse association was found between low levels of XIAP and disease relapse.
  • Survivin and its isoforms were undetectable in normal cervical tissues but upregulated in cancer samples.
  • Adenocarcinoma tumors expressed higher levels of survivin isoforms 2B and DeltaEx3.

Takeaway

This study looked at proteins that help cancer cells survive and found that one of them, XIAP, is linked to patients getting worse after treatment.

Methodology

Semiquantitative RT-PCR assays were used to analyze 41 cancer and 6 normal tissues.

Limitations

The study had a small sample size and some patients were lost to follow-up.

Participant Demographics

The study included 90 patients, with 41 samples analyzed, including various stages of cervical cancer.

Statistical Information

P-Value

p = 0.02 for XIAP and disease relapse; p = 0.001 and p = 0.04 for survivin isoforms in adenocarcinoma.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-6-45

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication